Roger Tung, Concert Pharmaceuticals CEO (Concert)
Concert gets BTD for alopecia drug, setting up a late-stage showdown with giant rival Pfizer
Concert Pharmaceuticals’ path to developing a drug that treats alopecia areata has been bumpy, but the pharma company scored a win Wednesday.
The FDA granted …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
